COCP

Cocrystal Pharma, Inc. (NASDAQ:COCP) is a biotechnology company founded in 2008 and publicly traded since 2012. The company is headquartered in Bothell, Washington, and specializes in discovering and developing antiviral therapeutic treatments for serious and chronic viral diseases. Cocrystal employs structure-based drug design technologies to create novel antiviral compounds, with a primary focus on treating hepatitis C virus, influenza, coronavirus, and norovirus infections. The company operates as a clinical-stage biopharmaceutical firm with several drug candidates in various stages of development.